Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Adaptive Biotechnologies ( (ADPT) ) has issued an announcement.
On December 30, 2025, Adaptive Biotechnologies announced that its 70%-owned subsidiary, Digital Biotechnologies, Inc., held an initial closing of a Series A Preferred Stock financing round, with total anticipated proceeds of up to $15 million. Upon completion of the full Series A round, Adaptive expects to retain a nearly 50% ownership stake in Digital Biotechnologies while continuing to consolidate the subsidiary’s financial results, signaling a shift toward a more balanced ownership structure that still preserves strategic and accounting control over this early-stage business.
The most recent analyst rating on (ADPT) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Adaptive Biotechnologies stock, see the ADPT Stock Forecast page.
Spark’s Take on ADPT Stock
According to Spark, TipRanks’ AI Analyst, ADPT is a Neutral.
Adaptive Biotechnologies’ overall score is driven by strong technical momentum and a positive earnings call, indicating operational improvements and strategic growth in the MRD segment. However, significant challenges in profitability and valuation metrics weigh down the score, highlighting the need for continued focus on financial stability and growth execution.
To see Spark’s full report on ADPT stock, click here.
More about Adaptive Biotechnologies
Adaptive Biotechnologies Corporation operates in the biotechnology industry, focusing on leveraging immune system biology and related technologies through its subsidiaries to develop products and services in areas such as diagnostics and therapeutics. The company maintains controlling and strategic ownership stakes in early-stage entities like Digital Biotechnologies, Inc., which it consolidates in its financial statements.
Average Trading Volume: 2,318,840
Technical Sentiment Signal: Buy
Current Market Cap: $2.55B
For a thorough assessment of ADPT stock, go to TipRanks’ Stock Analysis page.